GO:0032679 regulation of TRAIL production: Apoptosis Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032679 (regulation of TRAIL production) is a biological process that modulates the frequency, rate, or extent of TRAIL (TNFSF10) biosynthesis.
• TRAIL is a death ligand that triggers apoptosis in transformed cells while sparing most normal cells, making its regulation central to cancer immunotherapy and immune surveillance.
• TRAIL production is controlled at transcriptional, post-transcriptional, and epigenetic levels, with cFLIP and glutamine metabolism emerging as key regulators in pancreatic cancer.
• Natural products and pharmacological agents can sensitize cancer cells to TRAIL by modulating death receptor signaling and intracellular machinery.
• Engagement of TRAIL on natural killer cells triggers degranulation and IFNγ production, linking TRAIL regulation to innate immune activation.
• Experimental models for studying GO:0032679 include CRISPR knockout, point mutation, knock-in, and overexpression cell lines, combined with RNA-seq, proteomics, and functional apoptosis assays.
Description
Regulation of TRAIL production (GO:0032679) is a biological process that governs the frequency, rate, or extent of TRAIL (TNFSF10) biosynthesis. TRAIL, also known as Apo2L, is a member of the tumor necrosis factor superfamily that induces apoptosis through death receptors DR4 and DR5. Because TRAIL selectively kills cancer cells while largely sparing normal tissues, understanding how its production is regulated is critical for cancer biology and immunotherapy. Dysregulated TRAIL production contributes to immune evasion in tumors and to inflammatory liver diseases. Recent studies have identified metabolic and epigenetic mechanisms, such as glutamine-mediated regulation of cFLIP, that control TRAIL sensitivity and production in pancreatic cancer. Furthermore, TRAIL engagement on natural killer cells triggers degranulation and IFNγ production, highlighting its role in immune cell activation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0032679, its mechanisms, key genes, disease relevance, and experimental approaches.
regulation of TRAIL production At A Glance
| GO ID | GO:0032679 |
|---|---|
| GO term | regulation of TRAIL production |
| Ontology | biological_process |
| Synonym | regulation of TRAIL biosynthetic process |
| Major function | Modulates the frequency, rate, or extent of TRAIL (TNFSF10) biosynthesis |
| Related genes | TNFSF10, cFLIP, p53, and other apoptosis regulators |
| Disease relevance | Cancer, liver inflammation, immune evasion |
| Research methods | CRISPR knockout, RNA-seq, proteomics, apoptosis assays |
What Is GO:0032679?
GO:0032679, regulation of TRAIL production, is defined as any process that modulates the frequency, rate, or extent of TRAIL production. TRAIL (TNFSF10) is a cytokine that induces apoptosis upon binding to its receptors. This regulation can occur at multiple levels, including transcription, mRNA stability, translation, and post-translational processing. The term encompasses both positive and negative regulation of TRAIL biosynthesis, and it is a child of the broader regulation of cytokine production and regulation of apoptotic signaling pathways.
Why Is regulation of TRAIL production Important in Cell Biology?
Understanding the regulation of TRAIL production is essential because TRAIL is a key effector of immune surveillance and a promising anticancer therapeutic. Dysregulation of TRAIL production can lead to tumor immune evasion, chronic inflammation, and resistance to apoptosis. Moreover, TRAIL-based therapies are limited by resistance mechanisms, making it crucial to identify regulators of TRAIL production and sensitivity. Studies on natural products and pharmacological agents that modulate TRAIL signaling provide insights into overcoming resistance. Therefore, GO:0032679 is a focal point for cancer research, immunology, and drug discovery.
• TRAIL selectively induces apoptosis in cancer cells, making its regulation vital for cancer therapy.
• Dysregulated TRAIL production contributes to immune evasion in pancreatic cancer and other malignancies.
• TRAIL engagement on NK cells triggers degranulation and IFNγ production, linking it to innate immunity.
• Natural products can sensitize cancer cells to TRAIL by modulating death receptor signaling.
• Bufalin regulates TRAIL/TRAIL-R pathways and non-coding RNAs in various cancers.
• Glutamine metabolism epigenetically regulates cFLIP, affecting TRAIL resistance in pancreatic cancer.
• p53 regulates oxidative stress in skeletal muscle, potentially influencing TRAIL production.
• Liver inflammation involves cell death signals including TRAIL, highlighting its role in hepatology.
• CRISPR-based models enable precise dissection of TRAIL regulatory networks.
• Targeting TRAIL production regulators may overcome resistance to apoptosis-based therapies.
What Happens During regulation of TRAIL production?
Transcriptional Control of TRAIL Expression
In simple terms: The cell decides how much TRAIL mRNA to make based on signals.
TRAIL production is initiated by transcription of the TNFSF10 gene, which is regulated by various transcription factors and epigenetic modifications. For example, glutamine-mediated epigenetic regulation of cFLIP can influence TRAIL sensitivity and production in pancreatic cancer. p53, a tumor suppressor, regulates oxidative stress and may indirectly affect TRAIL expression. Natural products can modulate death receptor signaling and TRAIL production.
Post-transcriptional and Translational Regulation
In simple terms: After mRNA is made, the cell controls how much protein is produced.
TRAIL mRNA stability and translation efficiency are modulated by microRNAs and RNA-binding proteins. Bufalin has been shown to regulate non-coding RNAs that impact TRAIL/TRAIL-R pathways. These mechanisms ensure rapid adjustments in TRAIL protein levels in response to cellular stress or immune signals.
Post-translational Processing and Secretion
In simple terms: TRAIL protein is processed and released from the cell to act on others.
TRAIL is synthesized as a type II transmembrane protein that can be cleaved by proteases to release a soluble form. This processing is regulated by intracellular machinery including caspases and metalloproteinases. The balance between membrane-bound and soluble TRAIL affects its apoptotic activity.
Feedback and Crosstalk with Apoptotic Machinery
In simple terms: The cell's death machinery talks back to control TRAIL production.
TRAIL production is influenced by cFLIP, an anti-apoptotic protein that modulates death receptor signaling. Glutamine metabolism regulates cFLIP epigenetically, thereby affecting TRAIL resistance. Additionally, TRAIL engagement on NK cells triggers degranulation and IFNγ production, creating a feedback loop.
Key Genes Involved in GO:0032679 regulation of TRAIL production
The following genes and proteins are key players in the regulation of TRAIL production and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFSF10 | Encodes TRAIL, the ligand that induces apoptosis | Central to GO:0032679; target for cancer therapy |
| CFLAR (cFLIP) | Anti-apoptotic regulator of death receptor signaling | Glutamine-mediated epigenetic regulation affects TRAIL resistance |
| TP53 | Tumor suppressor regulating oxidative stress and apoptosis | May indirectly regulate TRAIL production |
| DR4 (TNFRSF10A) | Death receptor for TRAIL | Mediates TRAIL-induced apoptosis |
| DR5 (TNFRSF10B) | Death receptor for TRAIL | Mediates TRAIL-induced apoptosis |
| CASP8 | Initiator caspase in TRAIL apoptotic pathway | Downstream effector of TRAIL signaling |
| CASP3 | Executioner caspase | Mediates apoptosis downstream of TRAIL |
| FADD | Adaptor protein in death receptor signaling | Links TRAIL receptors to caspase activation |
| NFKB1 | Transcription factor regulating immune and apoptotic genes | Modulates TRAIL expression |
| MAPK1 | Kinase involved in stress and apoptotic signaling | Regulates TRAIL sensitivity |
| AKT1 | Survival kinase | Influences TRAIL resistance |
| JAK2 | Janus kinase in cytokine signaling | Bufalin modulates JAK/STAT and TRAIL pathways |
| STAT3 | Transcription factor in immune regulation | Linked to TRAIL/TRAIL-R regulation |
| MTOR | Kinase regulating cell growth and survival | Bufalin targets mTOR and TRAIL pathways |
| CTNNB1 | Beta-catenin in Wnt signaling | Bufalin modulates Wnt/β-catenin and TRAIL |
| IFNG | Interferon gamma, produced upon TRAIL engagement in NK cells | Links TRAIL to immune activation |
| GLS | Glutaminase, enzyme in glutamine metabolism | Glutamine metabolism regulates cFLIP and TRAIL resistance |
How Is regulation of TRAIL production Regulated?
Regulation of TRAIL production is controlled by multiple signaling pathways and metabolic cues. Glutamine metabolism epigenetically regulates cFLIP, which in turn modulates TRAIL resistance in pancreatic cancer. The JAK/STAT, Wnt/β-catenin, and mTOR pathways are also implicated in regulating TRAIL/TRAIL-R signaling, as shown for bufalin. Additionally, p53 regulates oxidative stress in skeletal muscle, which may influence TRAIL production. Natural products can sensitize cancer cells to TRAIL by modulating death receptors and intracellular machinery. These layers of regulation ensure that TRAIL production is tightly controlled in response to immune and stress signals.
regulation of TRAIL production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFSF10 | Cancer, immune evasion | CRISPR knockout in cancer cell lines |
| CFLAR (cFLIP) | Pancreatic cancer, TRAIL resistance | Point mutation or overexpression in pancreatic cells |
| TP53 | Skeletal muscle oxidative stress | Knockout in muscle cells |
| JAK2/STAT3 | Cancer, inflammation | Knock-in reporter for TRAIL production |
| IFNG | NK cell activation | Overexpression in NK cells |
Cancer and Immune Evasion
Dysregulated TRAIL production contributes to immune evasion in various cancers. In pancreatic cancer, glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL. Natural products and pharmacological agents can restore TRAIL sensitivity by modulating death receptor signaling. Bufalin regulates TRAIL/TRAIL-R pathways and non-coding RNAs in different cancers. Therefore, targeting regulators of TRAIL production is a promising therapeutic strategy.
Liver Inflammation
TRAIL is involved in cell death signals during liver inflammation. Hepatocyte apoptosis triggered by TRAIL contributes to inflammatory liver diseases. Understanding how TRAIL production is regulated in the liver may lead to new treatments for hepatitis and cirrhosis.
Immune Cell Activation
Engagement of TRAIL on human natural killer cells triggers degranulation and IFNγ production. This links TRAIL regulation to innate immune responses and suggests that modulating TRAIL production could enhance NK cell activity against tumors.
From regulation of TRAIL production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate TRAIL production? | CRISPR knockout cell line |
| Does a specific mutation in gene Y affect TRAIL production? | Point mutation knock-in |
| Can we tag TRAIL for live imaging? | Tagged knock-in (e.g., GFP-TRAIL) |
| Does overexpression of gene Z increase TRAIL production? | Overexpression cell line |
| What is the epigenetic regulation of cFLIP? | Knockout of GLS in pancreatic cancer cells |
| How does TRAIL engagement affect NK cells? | Overexpression of TRAIL in NK cells |
How to Study the regulation of TRAIL production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of TNFSF10 and related genes | Transcriptional regulation of TRAIL production |
| Proteomics | TRAIL protein abundance and modifications | Post-transcriptional regulation |
| Western blot | TRAIL protein levels | Validation of production changes |
| Caspase activity assay | Apoptosis induction | Functional impact of TRAIL production |
| CRISPR screen | Genes affecting TRAIL production | Discovery of novel regulators |
| Flow cytometry | Surface TRAIL and death receptor levels | Immune cell analysis |
| ELISA | Soluble TRAIL concentration | Secretion and processing |
| ChIP-seq | Transcription factor binding at TNFSF10 locus | Transcriptional control |
RNA-seq and Transcriptomics
RNA sequencing can quantify TNFSF10 mRNA levels and identify transcriptional regulators of TRAIL production. This method is useful for screening candidate genes or pathways that modulate TRAIL expression.
Proteomics and Immunoblotting
Proteomic approaches and Western blotting measure TRAIL protein levels and post-translational modifications. They are essential for validating changes in TRAIL production observed at the mRNA level.
Apoptosis Assays
Functional apoptosis assays, such as caspase-3/7 activity and Annexin V staining, assess the biological impact of altered TRAIL production. These assays link regulation of TRAIL production to cell death outcomes.
CRISPR Screening
Genome-wide CRISPR screens can identify genes that regulate TRAIL production or sensitivity. This unbiased approach reveals novel regulators and pathways.
How CRISPR Can Be Used to Study GO:0032679 regulation of TRAIL production
Knockout
CRISPR knockout of candidate genes (e.g., CFLAR, GLS) can determine their role in regulating TRAIL production. Knockout cell lines are valuable for loss-of-function studies.
Point Mutation
Introducing specific point mutations (e.g., in TP53 or CFLAR) allows researchers to dissect the precise residues or domains involved in TRAIL regulation. This is useful for mimicking disease-associated variants.
Knock-in
Knock-in of reporter tags (e.g., GFP) into the TNFSF10 locus enables real-time monitoring of TRAIL production. This approach provides dynamic insights into regulation.
Overexpression
Overexpression of TRAIL or its regulators (e.g., IFNG) can test gain-of-function effects on apoptosis and immune activation. This is particularly useful for studying TRAIL sensitization.
How EDITGENE Supports regulation of TRAIL production Research
Researchers studying regulation of TRAIL production-related genes often need to determine whether a candidate gene is causally involved in TRAIL biosynthesis, secretion, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of TRAIL production research.
Frequently Asked Questions About regulation of TRAIL production
What is GO:0032679?
GO:0032679 is the Gene Ontology term for regulation of TRAIL production, defined as any process that modulates the frequency, rate, or extent of TRAIL biosynthesis.
What is TRAIL?
TRAIL (TNFSF10) is a cytokine that induces apoptosis in cancer cells by binding to death receptors DR4 and DR5.
What genes are involved in regulation of TRAIL production?
Key genes include TNFSF10, CFLAR (cFLIP), TP53, and metabolic genes like GLS.
How is TRAIL production regulated?
TRAIL production is regulated at transcriptional, post-transcriptional, and epigenetic levels, with glutamine metabolism and cFLIP playing critical roles.
Why is regulation of TRAIL production important in cancer?
Dysregulated TRAIL production leads to immune evasion and resistance to apoptosis, making it a therapeutic target.
What experimental models are used to study GO:0032679?
CRISPR knockout, point mutation, knock-in, and overexpression cell lines, combined with RNA-seq and apoptosis assays.
How does glutamine metabolism affect TRAIL resistance?
Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.
Can natural products modulate TRAIL production?
Yes, natural products can sensitize cancer cells to TRAIL by modulating death receptor signaling and intracellular machinery.
What is the role of TRAIL in NK cells?
Engagement of TRAIL on human natural killer cells triggers degranulation and IFNγ production.
How can CRISPR help study regulation of TRAIL production?
CRISPR enables knockout, knock-in, and overexpression of candidate genes to dissect their roles in TRAIL production and signaling.
Conclusion
Regulation of TRAIL production (GO:0032679) is a critical biological process that controls the availability of TRAIL, a potent apoptosis-inducing cytokine. Its dysregulation is implicated in cancer immune evasion, liver inflammation, and resistance to therapy. Advances in CRISPR-based models and multi-omics approaches are uncovering novel regulators such as cFLIP and metabolic pathways. Continued research into GO:0032679 will inform the development of TRAIL-based therapeutics and immunotherapies. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Brenner C et al.. 2013. Decoding cell death signals in liver inflammation.. J Hepatol 59(3):583-94 PMID: 23567086
- 2. Kim JH et al.. 2024. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.. Exp Mol Med 56(4):1013-1026 PMID: 38684915
- 3. Höfle J et al.. 2022. Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells.. EMBO Rep 23(8):e54133 PMID: 35758160
- 5. Beyfuss K et al.. 2018. A systematic review of p53 regulation of oxidative stress in skeletal muscle.. Redox Rep 23(1):100-117 PMID: 29298131
- 7. Shahwar D et al.. 2019. Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers.. Int J Mol Sci 20(8) PMID: 31022877
- 8. Farooqi AA et al.. 2023. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs.. Molecules 28(5) PMID: 36903477
